Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: li3511 who wrote (8417)	12/4/2009 9:12:16 AM
From: willy61	Read Replies (1) \| Respond to of 63332

Li I hope you are right but Dr. Cheng at Immunomedics has told numerous people who call that UCB is an old line company that prefers to release results at major conferences and does mention Eular as a possibility without saying for sure. I wasnt at the annual so I dont know if the analysts need to see this data before recommending and it doesnt make sense to me . Neither does telling shareholders that there will be no reccommendations before the data is released. If anyone can call the company and get a different response that would be appreciated.